A Study to Evaluate the Efficacy and Safety of ICP-488 in Participants With Primary Sjögren's Syndrome
NCT07727486
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
240
Enrollment
INDUSTRY
Sponsor class
Conditions
Primary Sjögren's Syndrome
Interventions
DRUG:
ICP-488 Tablets
DRUG:
ICP-488 Placebo
Sponsor
Beijing InnoCare Pharma Tech Co., Ltd.